Akebia Therapeutics
AKBA
#7765
Rank
NZ$0.61 B
Marketcap
NZ$2.31
Share price
-5.00%
Change (1 day)
-31.23%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: NZ$0.61 Billion

As of January 2026 Akebia Therapeutics has a market cap of NZ$0.61 Billion. This makes Akebia Therapeutics the world's 7765th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.61 B-19.38%
2025NZ$0.76 B0.82%
2024NZ$0.75 B104.23%
2023NZ$0.36 B120.95%
2022NZ$0.16 B-71.12%
2021NZ$0.57 B3.21%
2020NZ$0.56 B-50.88%
2019NZ$1.14 B18.49%
2018NZ$0.96 B-2.63%
2017NZ$0.98 B71.84%
2016NZ$0.57 B-0.5%
2015NZ$0.57 B91.27%
2014NZ$0.30 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Akebia Therapeutics was reported to be:

NZ$0.64 Billion
by Nasdaq info icon info icon
NZ$0.64 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
NZ$303.40 B 49,376.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$473.36 B 77,092.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
NZ$891.56 B 145,289.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$1.28 B 108.90%๐Ÿ‡บ๐Ÿ‡ธ USA